DC-05
CAS: 890643-16-0
Ref. 3D-QKB64316
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
DC-05
Beschreibung:
DC-05 is a non-nucleoside inhibitor of DNA methyltransferases that has been shown to suppress tumor suppressor genes in cancer cells. It was tested for the first time in the treatment of kidney cancer. DC-05 is a prodrug that is converted to its active form by hydrolysis, which inhibits DNA methylation and prevents cell proliferation. The drug also acts as a diagnostic agent, as it can be used to detect the presence of epidermal growth factor receptor (EGFR) mutations in bladder cancers using immunohistochemical staining.
DC-05 has been shown to inhibit the growth of human bladder cancer cells that are resistant to cisplatin and oxaliplatin.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
383.49 g/mol
Formel:
C25H25N3O
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
